Watchlist Price Alert

Design Therapeutics Inc. (DSGN)

NASDAQ: DSGN · Real-Time Price · USD

3.69

-0.18 (-4.65%)

At close: Jun 17, 2025, 3:59 PM

3.68

-0.14%

After-hours: Jun 17, 2025, 04:04 PM EDT

Design Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-49.59M	-66.86M	-63.31M	-35.53M	-8.28M	-2.05M
Depreciation & Amortization	-5.6M	537K	406K	129K	5K	n/a
Stock-Based Compensation	13.07M	13.09M	10.93M	4.69M	450K	n/a
Other Working Capital	226K	1.97M	-3.39M	-1.02M	-398K	1.81M
Other Non-Cash Items	n/a	-6.05M	-1.33M	19K	38K	95K
Deferred Income Tax	n/a	n/a	n/a	-77K	-71K	n/a
Change in Working Capital	-993K	728K	1.99M	1.4M	-811K	1.81M
Operating Cash Flow	-43.1M	-58.56M	-51.32M	-29.38M	-8.67M	-139K
Capital Expenditures	-340K	-256K	-918K	-1.54M	-76K	n/a
Cash Acquisitions	n/a	n/a	39K	52.11K	33.48K	n/a
Purchase of Investments	-230.18M	-224.7M	-313M	-86.26M	-55.59M	n/a
Sales Maturities Of Investments	274.47M	277.5M	92.89M	34.16M	22.1M	n/a
Other Investing Acitivies	n/a	n/a	39K	-52.11K	-33.48K	n/a
Investing Cash Flow	43.95M	52.54M	-220.99M	-53.64M	-33.56M	n/a
Debt Repayment	n/a	n/a	n/a	n/a	44.53M	196K
Common Stock Repurchased	477K	305K	339K	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	513K	724K	235K	228K	-44.73M	n/a
Financial Cash Flow	513K	724K	235.00	379.21K	44.53M	196K
Net Cash Flow	1.36M	-5.3M	-272.07M	296.19M	2.3M	57K
Free Cash Flow	-43.45M	-58.82M	-52.23M	-30.91M	-8.74M	-139K